Immetacyte Overview

  • Year Founded
  • 2008

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 1

Employees

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 1

Immetacyte General Information

Description

Developer of tumor-infiltrating lymphocyte therapy based in Manchester, United Kingdom. The company specializes in providing patient-specific immunotherapy and uses T cells isolated from the patient's cancer that are cancer specific, allowing the patient's own T cells to fight their cancer.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • 48 Grafton Street
  • Manchester M13 9XX
  • England, United Kingdom
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Acquirer
Corporate Office
  • 48 Grafton Street
  • Manchester M13 9XX
  • England, United Kingdom

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Immetacyte Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Immetacyte‘s full profile, request access.

Request a free trial

Immetacyte Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Immetacyte FAQs

  • When was Immetacyte founded?

    Immetacyte was founded in 2008.

  • Where is Immetacyte headquartered?

    Immetacyte is headquartered in Manchester, United Kingdom.

  • What is the size of Immetacyte?

    Immetacyte has 1 total employees.

  • What industry is Immetacyte in?

    Immetacyte’s primary industry is Drug Discovery.

  • Is Immetacyte a private or public company?

    Immetacyte is a Private company.

  • What is the current valuation of Immetacyte?

    The current valuation of Immetacyte is .

  • What is Immetacyte’s current revenue?

    The current revenue for Immetacyte is .

  • When was Immetacyte acquired?

    Immetacyte was acquired on 02-Mar-2020.

  • Who acquired Immetacyte?

    Immetacyte was acquired by Instil Bio.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process